Spectroscopy From Duodenum

Completed · Not applicable

Conditions studied: Pancreatic Adenocarcinoma

In brief

Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.

Key facts

Study ID

NCT01753479

Run by

Olympus Corporation

People needed

445

Starts

2013-01-01

Expected to finish

2016-06-30

Last updated by the study team

2017-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Common inclusion criterion
• Age is 18 years or older.
• Informed consent was obtained.
• Inclusion criterion for normal cohort
• An upper GI endoscopy is scheduled to check upper abdominal symptoms.
• No findings of pancreatic disorder as documented by CT or MRI or EUS
• Inclusion criterion for PC suspicious cohort * A EUS or ERCP is scheduled to suspected pancreatic disorder.

You may not qualify if…

• Common exclusion criterion
• Severe cardiac disease
• Severe respiratory disease
• Bleeding disorders
• Pregnancy

Where it is running

• Mayo Clinic Florida — Jacksonville, Florida, United States
• The University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States
• Hôpital Erasme — Brussels, Brussels Capital, Belgium
• Università Cattolica del Sacro Cuore — Rome, Lazio, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.